HLA class II protein modulators (Nextera AS)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHLA class II protein modulators (Nextera AS)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistocompatibility antigens class II modulators
TargetsHistocompatibility antigens class II
Therapy Area/IndicationsCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorway
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNextera Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNextera Therapeutics
Active IndicationsN/A
Inactive IndicationsCrohn Disease

Other Information

ATC CodeN/A
Related LinksN/A